rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2005-4-27
|
pubmed:abstractText |
Treatment with interferon-alpha has been shown to be effective in one-third of hepatitis B e antigen-positive chronic hepatitis B patients, but is clinically associated with relevant adverse events.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0269-2813
|
pubmed:author |
pubmed-author:AkarcaU SUS,
pubmed-author:CakalogluYY,
pubmed-author:FlinkH JHJ,
pubmed-author:GerkenGG,
pubmed-author:HBV 99-01 Study Group,
pubmed-author:HanselB CBC,
pubmed-author:JanssenH L AHL,
pubmed-author:SchalmS WSW,
pubmed-author:SenturkHH,
pubmed-author:SimonCC,
pubmed-author:SoT M KTM,
pubmed-author:VerheyEE,
pubmed-author:ZeuzemSS,
pubmed-author:de ManR ARA,
pubmed-author:van ZonneveldMM
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1163-71
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15854180-Adult,
pubmed-meshheading:15854180-Antiviral Agents,
pubmed-meshheading:15854180-Bacterial Infections,
pubmed-meshheading:15854180-Double-Blind Method,
pubmed-meshheading:15854180-Female,
pubmed-meshheading:15854180-Hemorrhage,
pubmed-meshheading:15854180-Hepatitis B, Chronic,
pubmed-meshheading:15854180-Humans,
pubmed-meshheading:15854180-Interferon-alpha,
pubmed-meshheading:15854180-Male,
pubmed-meshheading:15854180-Polyethylene Glycols,
pubmed-meshheading:15854180-Recombinant Proteins,
pubmed-meshheading:15854180-Risk Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|